![]() ![]() ![]() While raising $9 billion through a series of aggressive (and falsified) claims and dozens of private investors, the company’s spiking net worth caught Carreyrou’s attention a few years ago. Founded in 2003, when Holmes was just 19, the company’s claim to “fame” was its revolutionary blood-testing system, which touted the detection of everything from high cholesterol to hepatitis C to cancer using only one drop of blood. A deep investigative report on the sensationalistic downfall of multibillion-dollar Silicon Valley biotech startup Theranos.īasing his findings on hundreds of interviews with people inside and outside the company, two-time Pulitzer Prize–winning Wall Street Journal reporter Carreyrou rigorously examines the seamy details behind the demise of Theranos and its creator, Elizabeth Holmes. ![]()
0 Comments
Leave a Reply. |